论文部分内容阅读
癌性胸/腹水是晚期癌症的严重并发症之一,如能及时有效地治疗和控制,可以提高患者生活质量,延长生存期。我们采用穿刺抽吸胸/腹水后腔内注射白细胞介素—Ⅰ(IL—2)加5—氟脲嘧啶(5—FU)的方法治疗癌性胸/腹水60例,临床效果满意,报告如下: 临床资料 1、本组60例患者均于胸/腹水中查到癌细胞而确诊为癌性胸/腹水,其中癌性胸水36例,癌性腹水24例。男40例,年龄40—80岁,原发肿瘤部位:肺Ca,乳腺Ca,结
Cancerous thoracic/ascites is one of the serious complications of advanced cancer. If it can be timely and effectively treated and controlled, the quality of life of patients can be improved and the survival period can be prolonged. We used puncture aspiration of the chest / ascites after intraluminal injection of interleukin -1 (IL -2) plus 5-fluorouracil (5 - FU) method for the treatment of 60 cases of cancerous chest / ascites, clinical results are satisfactory, the report is as follows : Clinical data 1. 60 patients in this group were all diagnosed as cancerous chest/ascites in the thoracic/ascites fluid, including 36 cases of cancerous pleural effusion and 24 cases of cancerous ascites. 40 males, aged 40-80 years, primary tumor site: lung Ca, breast Ca, knot